ASTM E 2329 : 2014
|
Standard Practice for Identification of Seized Drugs |
ASTM E 2363 : 2005
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM E 2326 : 2009
|
Standard Practice for Education and Training of Seized-Drug Analysts |
ASTM D 6161 : 1998
|
Standard Terminology Used for Crossflow Microfiltration, Ultrafiltration, Nanofiltration, and Reverse Osmosis Membrane Processes |
ASTM E 2548 : 2007
|
Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis |
ASTM E 2363 : 2014 : REDLINE
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM D 6161 : 2019
|
Standard Terminology Used for Microfiltration, Ultrafiltration, Nanofiltration, and Reverse Osmosis Membrane Processes |
ASTM E 2363 : 2005 : REV B
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM F 2725 : 2008
|
Standard Guide for European Union's Registration, Evaluation, and Authorization of Chemicals (REACH) Supply Chain Information Exchange |
ASTM E 2549 : 2009
|
Standard Practice for Validation of Seized-Drug Analytical Methods |
ASTM E 2548 : 2011 : EDT 1
|
Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis |
ASTM E 1605 : 2001 : REV B
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 2327 : 2010
|
Standard Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis |
ASTM E 2363 : 2004
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM E 2548 : 2016 : REDLINE
|
Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis |
ASTM E 2329 : 2017 : REDLINE
|
Standard Practice for Identification of Seized Drugs |
ASTM E 2329 : 2010
|
Standard Practice for Identification of Seized Drugs |
ASTM E 2363 : 2006
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM E 1605 : 2000
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 1605 : 2018
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 1605 : 2018 : REV A
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 1605 : 2001 : REV A
|
Standard Terminology Relating to Lead in Buildings |
ASTM F 2725 : 2011 : REDLINE
|
GUIDE FOR EUROPEAN UNION'S REGISTRATION, EVALUATION, AND AUTHORIZATION OF CHEMICALS (REACH) SUPPLY CHAIN INFORMATION EXCHANGE |
ASTM E 2549 : 2014
|
Standard Practice for Validation of Seized-Drug Analytical Methods (Withdrawn 2023) |
ASTM E 2329 : 2009
|
Standard Practice for Identification of Seized Drugs |
ASTM E 1605 : 2003 : EDT 1
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 2329 : 2004
|
Standard Practice for Identification of Seized Drugs |
ASTM D 6161 : 2005
|
Standard Terminology Used for Microfiltration, Ultrafiltration, Nanofiltration and Reverse Osmosis Membrane Processes |
ASTM E 2548 : 2011
|
Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis |
ASTM F 2725 : 2011
|
Standard Guide for European Union's Registration, Evaluation, and Authorization of Chemicals (REACH) Supply Chain Information Exchange |
ASTM E 2549 : 2014 : REDLINE
|
Standard Practice for Validation of Seized-Drug Analytical Methods |
ASTM F 2725 : 2019
|
Standard Guide for European Union's Registration, Evaluation, and Authorization of Chemicals (REACH) Supply Chain Information Exchange |
ASTM E 1605 : 2003
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 1605 : 2018 : REV B
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 2326 : 2004
|
Standard Practice for Education and Training of Seized-Drug Analysts |
ASTM E 1605 : 2004
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 2327 : 2015
|
Standard Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis |
ASTM E 2363 : 2004 : REV A
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM E 2326 : 2014 : REDLINE
|
Standard Practice for Education and Training of Seized-Drug Analysts |
ASTM E 2329 : 2017
|
Standard Practice for Identification of Seized Drugs |
ASTM D 6161 : 2010
|
Standard Terminology Used for Microfiltration, Ultrafiltration, Nanofiltration and Reverse Osmosis Membrane Processes (Withdrawn 2019) |
ASTM E 1605 : 2001
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 2363 : 2005 : REV A
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM E 2363 : 2006 : REV A
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM E 2326 : 2014
|
Standard Practice for Education and Training of Seized-Drug Analysts (Withdrawn 2023) |
ASTM E 1605 : 2004 : R2012
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 1605 : 2002
|
Standard Terminology Relating to Lead in Buildings |
ASTM E 2548 : 2016
|
Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis |
ASTM E 2363 : 2014
|
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry |
ASTM E 2327 : 2004
|
Standard Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis |
ASTM E 2327 : 2015 : EDT 1
|
Standard Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis (Withdrawn 2024) |